Healthpluser

Spread the love

<figure class="img_container" style="float:left;margin-right:10px;width:350px;;margin-bottom:5px;max-width:100%;"><img width="590" height="442" class="unveil" loading="eager" style="width:100%;max-height:100%" src="https://img.etb2bimg.com/files/cp/upload-1716881542-ethealthworld.webp" data-src="https://etimg.etb2bimg.com/photo/118276901.cms" captionrendered="1" alt=""><figcaption class="caption"></figcaption></figure>New Delhi: The manufacturing of medical devices such as CT scan, MRI and dialysis machines, which were completely imported earlier, have commenced in India, Amit Aggarwal, secretary, department of pharmaceuticals has confirmed. According to Aggarwal, these devices are being manufactured under the Production Linked Incentive (PLI) scheme – a govt programme under the Make-in-India initiative that offers financial incentives to businesses to boost domestic manufacturing. "We have commissioned a total 19 projects for producing 46 medical devices that are imported under the <a id="8941225" type="General" weightage="20" keywordseo="PLI-scheme" source="Orion" class="news-keywords" href="/tag/pli+scheme">PLI scheme</a>," he added. <!– PROMOSLOT_M –>Aggarwal said the outlay for manufacturing incentive and infrastructure and ecosystem development outlay has gone up by 44per cent – from Rs 282 crore in 2024-25 to Rs 405 crore – in the current budget. To boost domestic manufacturing of key medicines, the pharma secretary said, the govt has commissioned production of more than 175 high-value drugs including for cancer, vaccines, rare diseases and auto-immune disorders under PLI scheme. <!– PROMOSLOT_M –><!– PROMOSLOT –>"Production of critical antibiotics like Penicillin-G and Clavulanic Acid have started in the country. Also, we are expecting the production of Rifampicin, a key drug used for Tuberculosis treatment, to commence next year," he explained. The market size of the medical devices sector in India is estimated to be $11 billion (approximately, Rs 90,000 Cr) in 2020 and its share in the global medical device market is estimated to be 1.5per cent. <!– PROMOSLOT_M –>In 2023, the Union Cabinet adopted the National Medical Devices Policy with an aim to increase domestic production and reduce imports of such equipment. The policy aimed to establish centres of excellence in academic and research institutions, innovation hubs, ‘plug and play’ infrastructures and support to start-ups. <!– PROMOSLOT –>Officials said for brand positioning, the policy envisages creation of a dedicated export promotion council for the sector which will initiate studies and projects for learning from best global practices of manufacturing and skilling system to explore the feasibility of adapting such successful models in India. <!– PROMOSLOT_M –>The current budget, 2025-26, has also seen a more than 200per cent increase in outlay for Promotion of Research and Innovation in Pharma MedTech (PRIP) scheme. "We are a leader in generic pharmacy. But, now the govt is encouraging scientists as well as institutions to come up with innovative technologies, especially in the six priority areas covering drug discovery & development, medical devices, stem cell therapy, treatment of drug-resistant patients, etc," said an official. <!– PROMOSLOT_M –><!– PROMOSLOT –>India cuts duty on bourbon, some wines Amid pressure from the US, govt has slashed the import duty on bourbon whiskey from 150per cent to 100per cent and lowered the tariffs on several varieties of wines. Duty on wines made of fresh grapes, and vermouth, as well as some other fermented beverages and unadulterated ethyl alcohol with 80per cent alcohol strength have been cut from 150per cent to 100per cent. The import of these products together added up to around $1 billion during the last financial year. In case of bourbon, the basic customs duty has been fixed at 50per cent, with agricultural cess of 50per cent also imposed. </body>","next_sibling":[{"msid":118243419,"title":"Dexcom beats fourth-quarter sales, reiterates 2025 revenue forecast","entity_type":"ARTICLE","link":"/news/medical-devices/dexcom-beats-fourth-quarter-sales-reiterates-2025-revenue-forecast/118243419","link_next_mobile":"/news/medical-devices/dexcom-beats-fourth-quarter-sales-reiterates-2025-revenue-forecast/118243419?next=1","category_name":null,"category_name_seo":"medical-devices"}],"related_content":[],"seoschemas":false,"social_share":{"fb":"/information/medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes/118276857?utm_source=fb&utm_medium={{DEVICE_TYPE}}","x":"/information/medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes/118276857?utm_source=twitter&utm_medium={{DEVICE_TYPE}}","whatsapp":"/information/medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes/118276857?utm_source=wapp&utm_medium={{DEVICE_TYPE}}","linkdin":"/information/medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes/118276857?utm_source=linkedin&utm_medium={{DEVICE_TYPE}}","telegram":"/information/medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes/118276857?utm_source=telegram&utm_medium={{DEVICE_TYPE}}","copy":"/information/medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes/118276857?utm_source=copy&utm_medium={{DEVICE_TYPE}}"},"cat_msid":44909127,"cat_sub_msid":false,"msid":118276857,"entity_type":"ARTICLE","title":"India now manufactures CT, MRI, dialysis machines beneath PLI schemes","synopsis":"In response to Aggarwal, these gadgets are being manufactured beneath the Manufacturing Linked Incentive (PLI) scheme – a govt programme beneath the Make-in-India initiative that gives monetary incentives to companies to spice up home manufacturing. "We’ve got commissioned a complete 19 tasks for producing 46 medical gadgets which might be imported beneath the PLI scheme," he added.","titleseo":"medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes","standing":"ACTIVE","authors":[{"author_name":"Durgesh Nandan Jha","author_link":"/author/479213514/durgesh-nandan-jha","author_api_link":"/author/479213514","author_image":"https://etimg.etb2bimg.com/authorthumb/479213514.cms?width=250&height=250&imgsize=14813","author_additional":{"thumbsize":true,"msid":479213514,"author_name":"Durgesh Nandan Jha","author_seo_name":"Durgesh-Nandan-Jha","designation":"Senior Correspondent","agency":false}}],"analytics":{"feedback":0,"views":374,"shares":0,"engagementtimems":1862000},"Alttitle":{"minfo":""},"next_promo_stories":[{"id":"117674599","type":"next_article"}],"artag":"TOI.in","artdate":"2025-02-15 08:35:44","lastupd":"2025-02-15 17:49:49","breadcrumbTags":["medical equipment manufacturing","ct manufacturing","mri manufacturing","dialysis machine manufacturing","PLI scheme","CT scan machine manufacturing"],"secinfo":{"seolocation":"medical-devices/india-now-manufactures-ct-mri-dialysis-machines-under-pli-schemes"}}” data-type=”information” durgesh=”” id=”news_dtl_118276857″ jha=”” nandan=”” page-title=”India now manufactures CT, MRI, dialysis machines beneath PLI schemes”>

In response to Aggarwal, these gadgets are being manufactured beneath the Manufacturing Linked Incentive (PLI) scheme – a govt programme beneath the Make-in-India initiative that gives monetary incentives to companies to spice up home manufacturing. “We’ve got commissioned a complete 19 tasks for producing 46 medical gadgets which might be imported beneath the PLI scheme,” he added.

Learn by: 100 Trade Professionals

Learn by 100 Trade Professionals

New Delhi: The manufacturing of medical gadgets similar to CT scan, MRI and dialysis machines, which had been utterly imported earlier, have commenced in India, Amit Aggarwal, secretary, division of prescription drugs has confirmed.

Aggarwal stated the outlay for manufacturing incentive and infrastructure and ecosystem improvement outlay has gone up by 44per cent – from Rs 282 crore in 2024-25 to Rs 405 crore – within the present funds. To spice up home manufacturing of key medicines, the pharma secretary stated, the govt. has commissioned manufacturing of greater than 175 high-value medicine together with for most cancers, vaccines, uncommon ailments and auto-immune problems beneath PLI scheme.

“Manufacturing of essential antibiotics like Penicillin-G and Clavulanic Acid have began within the nation. Additionally, we predict the manufacturing of Rifampicin, a key drug used for Tuberculosis remedy, to begin subsequent yr,” he defined.

The market measurement of the medical gadgets sector in India is estimated to be $11 billion (roughly, Rs 90,000 Cr) in 2020 and its share within the world medical system market is estimated to be 1.5per cent.

In 2023, the Union Cupboard adopted the Nationwide Medical Units Coverage with an intention to extend home manufacturing and scale back imports of such gear. The coverage aimed to determine centres of excellence in tutorial and analysis establishments, innovation hubs, ‘plug and play’ infrastructures and assist to start-ups.

Officers stated for model positioning, the coverage envisages creation of a devoted export promotion council for the sector which is able to provoke research and tasks for studying from greatest world practices of producing and skilling system to discover the feasibility of adapting such profitable fashions in India.

The present funds, 2025-26, has additionally seen a greater than 200per cent enhance in outlay for Promotion of Analysis and Innovation in Pharma MedTech (PRIP) scheme. “We’re a frontrunner in generic pharmacy. However, now the govt. is encouraging scientists in addition to establishments to provide you with modern applied sciences, particularly within the six precedence areas overlaying drug discovery & improvement, medical gadgets, stem cell remedy, remedy of drug-resistant sufferers, and so on,” stated an official.

India cuts obligation on bourbon, some wines

Amid stress from the US, govt has slashed the import obligation on bourbon whiskey from 150per cent to 100per cent and lowered the tariffs on a number of sorts of wines. Responsibility on wines product of contemporary grapes, and vermouth, in addition to another fermented drinks and unadulterated ethyl alcohol with 80per cent alcohol energy have been reduce from 150per cent to 100per cent. The import of those merchandise collectively added as much as round $1 billion over the last monetary yr. In case of bourbon, the essential customs obligation has been fastened at 50per cent, with agricultural cess of 50per cent additionally imposed.